Pharvaris (PHVS) Common Equity (2019 - 2026)
Pharvaris' Common Equity was $349.65 trillion in Q2 2026, compared with $208.66 million a year earlier and up 26.4% from the prior quarter.
Powered by 
Analysis
Pharvaris (PHVS) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Pharvaris came in at $306.49 trillion.
- Common Equity shows a five-year compound annual growth rate of 1847.6% (FY2020 to FY2025).
- In earlier years, Common Equity was $289.81 million in FY2024 (-30.2%), $415.43 million in FY2023 (+164.1%), $157.31 million in FY2022 (-35.1%) and $242.54 million in FY2021 (+121.8%).
- The Q2 2026 figure marks the highest quarterly Common Equity since Q1 2024.
- Compared with a year earlier, Common Equity was higher in 1 of the last five quarters, with an average decline of 35.4%.
- The best year-over-year quarter for Common Equity over five years was Q1 2024 (growth of 181.5%); the worst was Q1 2025 (a decline of 100.0%).
- Per Business Quant data, PHVS's Common Equity in the three quarters before Q2 2026 was $276.69 trillion (Q1 2026), $315.78 trillion (Q4 2025) and $365.03 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.38 Bn | 1,098.96 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 613.84 Bn | 532.37 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 502.13 Bn | 475.24 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 367.76 Bn | 322.14 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.08 Bn | 262.07 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 262.03 Bn | 235.71 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 235.81 Bn | 191.21 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 190.97 Bn | 165.17 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 169.66 Bn | 116.31 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Pharvaris | 1.85 Bn | 475.89 Mn | - | 343.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 343.59 Mn |
| Mar 31, 2026 | 270.84 Mn |
| Dec 31, 2025 | 318.67 Mn |
| Sep 30, 2025 | 366.30 Mn |
| Jun 30, 2025 | 216.18 Mn |
| Mar 31, 2025 | 243.90 Mn |
| Dec 31, 2024 | 278.64 Mn |
| Sep 30, 2024 | 331.51 Mn |
| Jun 30, 2024 | 356.34 Mn |
| Mar 31, 2024 | 387.70 Mn |
| Dec 31, 2023 | 425.07 Mn |
| Sep 30, 2023 | 161.74 Mn |
| Jun 30, 2023 | 188.81 Mn |
| Mar 31, 2023 | 140.83 Mn |
| Dec 31, 2022 | 159.12 Mn |
| Sep 30, 2022 | 182.02 Mn |
| Jun 30, 2022 | 199.08 Mn |
| Mar 31, 2022 | 213.07 Mn |
| Dec 31, 2021 | 232.11 Mn |
| Sep 30, 2021 | 249.93 Mn |
API Access
Pharvaris Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=PHVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "PHVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=PHVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();